Loading company…
Neuronetics makes NeuroStar TMS, a non-invasive treatment device for major depressive disorder.
Neuronetics develops and manufactures NeuroStar TMS, a non-invasive neuromodulation device for patients with major depressive disorder who have not benefited from prior antidepressant treatment. The company is based in Pennsylvania, US, and was founded in 2001. It began trading on the Nasdaq global select market under ticker STIM in July 2018. Revenue increased from USD 52.8 million in FY 2018 to USD 62.7 million in FY 2019.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in